6,7,8-Trichloro-1,2,3,4-tetrahydroisoquinoline | 73075-53-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四氢异喹啉
• 英文名称: 6,7,8-Trichloro-1,2,3,4-tetrahydroisoquinoline
• CAS: 73075-53-3
• 化学式: C₉H₈Cl₃N
• 分子量: 236.528
• InChiKey: DYLOZSJRCGMHPX-UHFFFAOYSA-N

物化性质

• 沸点：
  342.0±42.0 °C(Predicted)
• 密度：
  1.406±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  6,7,8-Trichloro-1,2,3,4-tetrahydroisoquinoline 在 亚氨基二砜氯化物 、 三乙胺 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 反应 12.0h， 以41%的产率得到6,7,8-trichloro-N-[(6,7,8-trichloro-3,4-dihydro-1H-isoquinolin-2-yl)sulfonyl]-3,4-dihydro-1H-isoquinoline-2-sulfonamide
  参考文献：
  名称：

  亚氨基二硫酰胺。2.取代的1,2,3,4-四氢异喹啉基磺酰亚胺作为慢反应性过敏性物质的拮抗剂。

  摘要：

  作为研究N'，N'-双（芳烷基）亚氨基二硫酰胺的结构修饰对其选择性拮抗SRS-A活性能力的影响的一部分，研究了一些构象受限的结构。在这些具有构象受限的亚烷基侧链的衍生物中，取代的1,2,3,4-四氢异喹啉基磺酰亚胺产生了最佳的SRS-A拮抗剂活性和选择性。测试了这些化合物对部分纯化的SRS-A诱导的豚鼠回肠收缩的拮抗作用。在这一系列四氢异喹啉中，研究了芳环取代以及杂环尺寸的取代和变化对SRS-A拮抗剂活性和选择性的影响。

  DOI：

  10.1021/jm00352a028
• 作为产物：
  描述：

  2,3,4-三氯苯甲酸 在 manganese(IV) oxide 、 硫酸 、 diborane(6) 作用下， 以 四氢呋喃 、 二氯甲烷 、 苯 为溶剂， 反应 27.0h， 生成 6,7,8-Trichloro-1,2,3,4-tetrahydroisoquinoline
  参考文献：
  名称：

  Inhibitors of phenylethanolamine N-methyltransferase and epinephrine biosynthesis. 1. Chloro-Substituted 1,2,3,4-tetrahydroisoquinolines

  摘要：

  In a search for inhibitors of epinephrine biosynthesis as potential therapeutic agents, a series of 13 ring-chlorinated 1,2,3,4-tetrahydroisoquinolines was prepared. These compounds were tested initially for their ability to inhibit rabbit adrenal phenylethanolamine N-methyltransferase (PNMT) in vitro. Enzyme-inhibitor dissociation constants, determined for the six most potent members of the series, indicated the following order of decreasing potency: 7,8-Cl2 greater than 6,7,8-Cl3 greater than 7-Cl approximately 5,6,7,8-Cl4 greater than 5,7,8-Cl3. These compounds were subsequently examined for PNMT-inhibiting activity in intact rats and mice. 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline (13, SK&F 64139) was the most potent member of the series both in vitro and in vivo and is currently undergoing clinical investigation.

  DOI：

  10.1021/jm00179a007

文献信息

• Intramolecular friedel-crafts alkylations. II. An efficient synthesis of biologically active 1,2,3,4-tetrahydroisoquinolines
  作者：W.L. Mendelson、C.B. Spainhour、S.S. Jones、B.L. Lam、K.L. Wert

  DOI：10.1016/s0040-4039(00)92728-x

  日期：——

  A new synthesis of tetrahydroisoquinolines bearing electron withdrawing groups is presented. The scope and mechanism of the reaction are discussed. Many of these tetrahydroisoquinolines are potent inhibitors of the enzyme PNMT.

  提出了一种带有吸电子基团的四氢异喹啉的新合成方法。讨论了反应的范围和机理。这些四氢异喹啉中的许多是PNMT酶的有效抑制剂。
• MENDELSON W. L.; SPAINHOUR C. B. JR.; JONES S. S.; LAM B. L.; WERT K. L., TETRAHEDRON LETT., 1980, 21, NO 15, 1393-1396
  作者：MENDELSON W. L.、 SPAINHOUR C. B. JR.、 JONES S. S.、 LAM B. L.、 WERT K. L.

  DOI：——

  日期：——
• BONDINELL W. E.; CHAPIN F. W.; GIRARD G. R.; KAISER C.; KROG A. J.; PAVLO+, J. MED. CHEM., 1980, 23, NO 5, 506-511
  作者：BONDINELL W. E.、 CHAPIN F. W.、 GIRARD G. R.、 KAISER C.、 KROG A. J.、 PAVLO+

  DOI：——

  日期：——
• ALI, FADIA, EL-FEHAIL;GLEASON, J. G.;HILL, D. T.;KRELL, R. D.;KRUSE, C. H+, J. MED. CHEM., 1982, 25, N 10, 1235-1240
  作者：ALI, FADIA, EL-FEHAIL、GLEASON, J. G.、HILL, D. T.、KRELL, R. D.、KRUSE, C. H+

  DOI：——

  日期：——
• Inhibitors of phenylethanolamine N-methyltransferase and epinephrine biosynthesis. 1. Chloro-Substituted 1,2,3,4-tetrahydroisoquinolines
  作者：William E. Bondinell、Frederic W. Chapin、Gerald R. Girard、Carl Kaiser、Arnold J. Krog、Alex M. Pavloff、Mark S. Schwartz、Joanne S. Silvestri、Praful D. Vaidya

  DOI：10.1021/jm00179a007

  日期：1980.5

  In a search for inhibitors of epinephrine biosynthesis as potential therapeutic agents, a series of 13 ring-chlorinated 1,2,3,4-tetrahydroisoquinolines was prepared. These compounds were tested initially for their ability to inhibit rabbit adrenal phenylethanolamine N-methyltransferase (PNMT) in vitro. Enzyme-inhibitor dissociation constants, determined for the six most potent members of the series, indicated the following order of decreasing potency: 7,8-Cl2 greater than 6,7,8-Cl3 greater than 7-Cl approximately 5,6,7,8-Cl4 greater than 5,7,8-Cl3. These compounds were subsequently examined for PNMT-inhibiting activity in intact rats and mice. 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline (13, SK&F 64139) was the most potent member of the series both in vitro and in vivo and is currently undergoing clinical investigation.